US Edition
News from Holy City Sinner
We’ve assigned a media bias rating of unknown to Holy City Sinner. You can read more about our methodology here.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Holy City Sinner News
European Union · CanadaMazdutide is a once-weekly glucagon and glucagon-like peptide-1 receptor dual agonist developed for the treatment of type 2 diabetes (T2D) 1. This study assessed the efficacy and safety of mazdutide versus dulaglutide in participants with T2D on background oral anti-diabetic drugs. In this randomised phase 3 study, 731 participants with T2D were randomised 1:1:1 to receive mazdutide 4 mg, mazdutide 6 mg or dulaglutide 1.5 mg for 28 weeks. Both m…See the Story
Mazdutide versus Dulaglutide in Chinese Adults with Type 2 Diabetes
Coverage: 8 sources
Donald Trump · United StatesUS President Donald Trump used a prime-time address from the White House to play down public anxiety about the US economy, insisting it is on the mend despite rising inflation, slowing job growth and growing voter frustration ahead of the 2026 midterm elections. Follow our liveblog to see how the speech unfolded.See the Story
Trump Insists on the US Economy's Strength in Address to Nation
Coverage: 5 sources
Bernie Sanders · MontpelierRep. Becca Balint (D-VT) said she would consider running for independent Sen. Bernie Sanders’ seat should he decide not to run for reelection in 2030, NOTUS reports. Said Balint: “I’m not going to play coy and say ‘No, I’ve never thought about it,’ — of course I think about it.”See the Story
Becca Balint Eyes Bernie Sanders’ Seat
Coverage: 2 sources
